Skip to main content
TipRanks
Go Ultimate75% OFF

Bukwang Pharmaceutical Co., Ltd. (003000) Income Statement

Bukwang Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Bukwang Pharmaceutical Co., Ltd.'s total revenue was ₩56.99B, an increase of 33.84% from the same quarter last year. In Q2, Bukwang Pharmaceutical Co., Ltd.'s net income was ₩1.40B. See Bukwang Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
₩ 200.71B₩ 160.09B₩ 125.93B₩ 190.91B₩ 182.49B
₩ 95.72B₩ 74.34B₩ 50.05B₩ 79.43B₩ 75.76B
₩ 81.56B₩ 72.73B₩ 87.54B₩ 79.66B₩ 70.14B
Depreciation and Amortization₩ 5.49B₩ 4.11B₩ 4.29B₩ 5.12B₩ 4.84B
₩ 19.65B₩ 7.63B₩ -31.47B₩ 4.89B₩ 11.40B
₩ 14.16B₩ 1.62B₩ -37.50B₩ -230.64M₩ 5.62B
₩ -7.78B₩ -4.59B₩ -2.07B₩ -802.24M₩ -1.83B
₩ 6.39B₩ -2.97B₩ -39.57B₩ -1.03B₩ 3.79B
₩ 12.57B₩ -2.64B₩ -31.33B₩ -2.47B₩ -916.62M
Per Share Metrics
Basic EPS₩ 152.00₩ -38.59₩ -458.00₩ -36.15₩ -13.39
Diluted EPS₩ 152.00₩ -38.59₩ -457.67₩ -36.15₩ -13.39
Weighted Average Shares Outstanding98.67M68.45M68.41M68.45M68.46M
Weighted Average Shares Outstanding (Diluted)98.67M68.45M68.45M68.45M68.46M

Currency in KRW

Bukwang Pharmaceutical Co., Ltd. Earnings and Revenue History

-120B0120B240B-40 %0 %40 %80 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin